Clinical outcome of cystic fibrosis patients colonized by Scedosporium species following lung transplantation: A single-center 15-year experience

The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary

(2016) Shahid Husain et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Fungal epidemiology and diversity in cystic fibrosis patients over a 5-year period in a national reference center

(2016) S. Ziesing et al.   MEDICAL MYCOLOGY

Epidemiology of invasive respiratory disease caused by emerging non-Aspergillusmolds in lung transplant recipients

(2016) M. Peghin et al.   Transplant Infectious Disease

Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium

(2015) L. Sedlacek et al.   Journal of Cystic Fibrosis

The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report—2015; Focus Theme: Early Graft Failure

(2015) Roger D. Yusen et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Invasive mold infections in lung and heart-lung transplant recipients: Stanford University experience

(2015) R. Vazquez et al.   Transplant Infectious Disease

Case Report of Vertebral Osteomyelitis and Mycotic Abdominal Aortic Aneurysm Caused by Scedosporium apiospermum in a Lung Transplant Patient With Cystic Fibrosis

(2015) S. Thomson et al.   TRANSPLANTATION PROCEEDINGS

Epidemiology of Invasive Mold Infections in Lung Transplant Recipients

(2014) C. T. Doligalski et al.   AMERICAN JOURNAL OF TRANSPLANTATION

ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others

(2014) A.M. Tortorano et al.   CLINICAL MICROBIOLOGY AND INFECTION

Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis

(2014) Perrine Parize et al.   Journal of Cystic Fibrosis

Epidemiology, clinical manifestations, and outcomes ofScedosporiuminfections among solid organ transplant recipients

(2014) L.S. Johnson et al.   Transplant Infectious Disease

Emerging Fungal Infections in Solid Organ Transplant Recipients

(2013) Shmuel Shoham   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Disseminated Trichosporon mycotoxinivorans, Aspergillus fumigatus, and Scedosporium apiospermum Coinfection after Lung and Liver Transplantation in a Cystic Fibrosis Patient

(2012) S. Hirschi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Molecular identification tools for sibling species ofScedosporiumandPseudallescheria

(2012) M. Lackner et al.   MEDICAL MYCOLOGY

A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients

(2011) Shahid Husain et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Scedosporium apiospermumatrial mycetomas after lung transplantation for cystic fibrosis

(2011) F. Miraldi et al.   Transplant Infectious Disease

Disseminated Scedosporium/Pseudallescheria Infection after Double-Lung Transplantation in Patients with Cystic Fibrosis

(2010) F. Morio et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Chronic airway colonization byScedosporium apiospermumwith a fatal outcome in a patient with cystic fibrosis

(2010) Elisa Borghi et al.   MEDICAL MYCOLOGY

Abundance of Pseudallescheria/Scedosporium species in the Australian urban environment suggests a possible source for scedosporiosis including the colonization of airways in cystic fibrosis

(2010) Azian Harun et al.   MEDICAL MYCOLOGY

Heterothallism inScedosporium apiospermumand description of its teleomorphPseudallescheria apiospermasp. nov.

(2010) Fèlix Gilgado et al.   MEDICAL MYCOLOGY

Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients

(2010) Eliane M. Billaud et al.   MEDICAL MYCOLOGY

Antifungal Prophylaxis with Voriconazole or Itraconazole in Lung Transplant Recipients: Hepatotoxicity and Effectiveness

(2009) J. Cadena et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Detection of OccultScedosporiumSpecies in Respiratory Tract Specimens from Patients with Cystic Fibrosis by Use of Selective Media

(2009) C. C. Blyth et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Pseudallescheria boydii (Scedosporium species) in 3 Lung Transplant Recipients

(2009) Robert Sheu et al.   JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY

Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients

(2009) M. Berge et al.   Transplant Infectious Disease

Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 Patients

(2008) P. Troke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Infections Caused by Scedosporium spp.

(2008) K. J. Cortez et al.   CLINICAL MICROBIOLOGY REVIEWS

Ecology ofPseudallescheriaandScedosporiumspecies in human-dominated and natural environments and their distribution in clinical samples

(2008) J. Kaltseis et al.   MEDICAL MYCOLOGY

Selective Isolation of Pseudallescheria and Scedosporium Species from Respiratory Tract Specimens of Cystic Fibrosis Patients

(2008) R. Horré et al.   RESPIRATION

Fungal infections after lung transplantation

(2008) Amparo Solé et al.   Transplantation Reviews

Multifocal Scedosporium apiospermum spondylitis in a cystic fibrosis patient

(2007) S. Guignard et al.   Journal of Cystic Fibrosis